Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127980721 | 12798072 | 1 | I | 20160928 | 20160930 | 20160930 | EXP | CH-SM-2016-07702 | CH-ROCHE-1836851 | ROCHE | 0.00 | M | Y | 111.00000 | KG | 20160930 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127980721 | 12798072 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous drip | U | 103705 | 1 | DF | SOLUTION FOR INFUSION | QD | ||||||
| 127980721 | 12798072 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 100 | MG | FILM-COATED TABLET | QD | |||||||
| 127980721 | 12798072 | 3 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 127980721 | 12798072 | 4 | C | CONCOR 5 | 2 | Oral | 0 | 5 | MG | QD | |||||||||
| 127980721 | 12798072 | 5 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 127980721 | 12798072 | 6 | C | RENAGEL | SEVELAMER HYDROCHLORIDE | 1 | Oral | 0 | 800 | MG | FILM-COATED TABLET | BID | |||||||
| 127980721 | 12798072 | 7 | C | PANTOZOL (SWITZERLAND) | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 127980721 | 12798072 | 8 | C | NOVORAPID | INSULIN ASPART | 1 | Subcutaneous | 0 | |||||||||||
| 127980721 | 12798072 | 9 | C | ZYLORIC | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | TABLET | QD | |||||||
| 127980721 | 12798072 | 10 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 127980721 | 12798072 | 11 | C | NOVONORM | REPAGLINIDE | 1 | Oral | 0 | 2 | MG | TABLET | TID | |||||||
| 127980721 | 12798072 | 12 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 0 | 26 | IU | QD | ||||||||
| 127980721 | 12798072 | 13 | C | TRITTICO | TRAZODONE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | TABLET | QD | |||||||
| 127980721 | 12798072 | 14 | C | DEANXIT | FLUPENTIXOL DIHYDROCHLORIDEMELITRACEN HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | QD | ||||||||
| 127980721 | 12798072 | 15 | C | TARGIN | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Unknown | 0 | 1 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127980721 | 12798072 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127980721 | 12798072 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127980721 | 12798072 | Dyspnoea | |
| 127980721 | 12798072 | Hyperglycaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127980721 | 12798072 | 1 | 20160719 | 20160719 | 0 |